Table III.
Prevalence of comorbidities overall in patients with coronavirus disease 2019
| Comorbidity | % | N | Total | Count |
|---|---|---|---|---|
| Cardiovascular: | ||||
| Hypertension | 31.90 | 9818 | 30792 | 105 |
| Diabetes mellitus | 17.20 | 5122 | 29796 | 107 |
| Atherosclerotic disease | 9.20 | 2642 | 28806 | 102 |
| Smoking | 18.90 | 2980 | 15728 | 31 |
| Obesity | 27.90 | 2758 | 9870 | 9 |
| Heart failure | 5.90 | 554 | 9403 | 9 |
| Arrythmia | 5.01 | 65 | 1297 | 5 |
| Hyperlipidemia | 26.40 | 199 | 753 | 9 |
| Respiratory: | ||||
| COPD/CLD | 6.20 | 1643 | 26570 | 83 |
| Asthma | 7.80 | 555 | 7136 | 11 |
| Gastrointestinal: | ||||
| Hepatitis/liver disease/fatty liver | 2.40 | 459 | 19310 | 60 |
| Renal: | ||||
| CKD/ESRD | 6.20 | 1445 | 23149 | 58 |
| Neurologic: | ||||
| CVA/cerebrovascular disease | 3.50 | 320 | 9152 | 40 |
| Other: | ||||
| Cancer/malignancy | 4.40 | 1062 | 23962 | 66 |
| HIV/immunodeficiency | 1.60 | 216 | 13506 | 23 |
COPD – chronic obstructive pulmonary disease, CLD – chronic lung disease, CKD – chronic kidney disease, ESRD – end-stage renal disease, CVA – cerebrovascular accident, HIV – human immunodeficiency virus.